Chulani Karunatilake
Director Técnico/Científico/I+D en WEREWOLF THERAPEUTICS, INC. .
Fortuna: - $ al 30/04/2024
Perfil
Chulani Karunatilake is currently the Chief Technology Officer at Werewolf Therapeutics, Inc. He previously worked as Vice President at Nektar Therapeutics and Senior Vice President-Technical Operations at Maverick Therapeutics, Inc. He holds a doctorate degree from the University of Illinois and an undergraduate degree from the University of Colombo.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/01/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Chulani Karunatilake
| Empresas | Cargo | Inicio |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 15/06/2021 |
Antiguos cargos conocidos de Chulani Karunatilake.
| Empresas | Cargo | Fin |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Corporate Officer/Principal | - |
Formación de Chulani Karunatilake.
| University of Illinois | Doctorate Degree |
| University of Colombo | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| WEREWOLF THERAPEUTICS, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| Empresas privadas | 1 |
|---|---|
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Chulani Karunatilake